mRNA | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
October 16, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, OCTOBER 16, 2025

mRNA

mRNA

An employee works on the production line of CanSino Biologics Inc's single-dose vaccine against the coronavirus disease (Covid-19) in Tianjin, China April 25, 2021. Picture taken April 25, 2021. China Daily via REUTERS

China OKs its first mRNA vaccine, from drugmaker CSPC

Illustration: TBS

Can mRNA vaccines cure cancer?

 People enter a pharmacy next to a sign promoting flu shots in New York January 10, 2013. REUTERS/Andrew Kelly/File Photo

Researchers test mRNA technology for universal flu vaccine

Test tube labelled "Covid-19 Omicron variant test positive" is seen in this illustration picture taken January 15, 2022. Photo :Reuters

Prior Covid offers less protection vs Omicron; mRNA booster shot efficacy declines within months

Tests of HIV vaccine using mRNA technology have begun

Tests of HIV vaccine using mRNA technology have begun

Tests of HIV vaccine using mRNA technology have begun

Tests of HIV vaccine using mRNA technology have begun

Vials labelled "VACCINE Coronavirus Covid-19" and a syringe are seen in front of displayed words "OMICRON SARS-COV-2" in this illustration taken December 11, 2021. Photo :Reuters

'Significant increase' in protection vs Omicron from mRNA boosters, study says

A healthcare worker holds a vial of the Moderna Covid-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (Covid-19) pandemic in Manhattan in New York City, New York, US, January 29, 2021. Photo :Reuters

Moderna to produce millions of mRNA vaccines in Australia

REUTERS/Dado Ruvic/Illustration

Moderna asks investors to wait for full data on flu vaccine amid selloff

While Covid-19 jabs are new researchers have been working on messenger RNA technology for decades. Photo :AFP

US wants to produce one billion doses of mRNA vaccine a year

While Covid-19 jabs are new researchers have been working on messenger RNA technology for decades. Photo :AFP

From Covid to cancer: High hopes for 'versatile' mRNA

The headquarters of the European Medicines Agency (EMA), is seen in London, Britain, 25 April, 2017/ Reuters

EU drugs regulator looking at new possible side-effects of mRNA vaccines

Photo: BSS

Scientist explains how exactly Pfizer and Moderna vaccine work 

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net